LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
(NASDAQ: LFMD) Delayed: 3.22 +0.02 (0.63%)
Previous Close $3.20    52 Week High $ 
Open $3.19    52 Week Low $ 
Day High $3.31    P/E N/A 
Day Low $3.16    EPS $ 
Volume 1,184,007       

(NASDAQ: LFMDP) Delayed: 23.14 --0 (-0%)
Previous Close $23.14    52 Week High $ 
Open $23.14    52 Week Low $ 
Day High $23.14    P/E N/A 
Day Low $23.14    EPS $ 
Volume 61